| Brigitte Wildemann, MD
					(University Hospital Heidelberg, Department of Neurology) | The institution of Dr. Wildemann has received research support from Roche.  The institution of Dr. Wildemann has received research support from Novartis.  The institution of Dr. Wildemann has received research support from Argenx. Dr. Wildemann has received personal compensation in the range of $500-$4,999 for serving as a Conference participant with Neuraxpharm. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Speaker with Roche. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Soeaker with Instand. |